Nakasu Satoshi, Notsu Akifumi, Na Kiyong, Nakasu Yoko
Division of Neurosurgery, Kusatsu General Hospital, Kusatsu, Japan.
Department of Neurosurgery, Shiga University of Medical Science, Ohtsu, Japan.
Neurooncol Adv. 2020 Oct 16;2(1):vdaa129. doi: 10.1093/noajnl/vdaa129. eCollection 2020 Jan-Dec.
The incidence and clinical features of the malignant transformation of benign meningiomas are poorly understood. This study examined the risk of the malignant transformation of benign meningiomas after surgery or stereotactic radiosurgery.
We systematically reviewed studies published between 1979 and 2019 using PubMed, Scopus, and other sources. We analyzed pooled data according to the PRISMA guideline to clarify the incidence rate of malignant transformation (IMT) and factors affecting malignant transformation in surgically or radiosurgically treated benign meningiomas.
IMT was 2.98/1000 patient-years (95% confidence interval [CI] = 1.9-4.3) in 13 studies in a single-arm meta-analysis. Although the evidence level of the included studies was low, the heterogeneity of the incidence was mostly explained by the tumor location. In meta-regression analysis, skull base tumors had a significantly lower IMT than non-skull base tumors, but no gender association was observed. IMT after radiosurgery in 9 studies was 0.50/1000 person-years (95% CI = 0.02-1.38). However, a higher proportion of skull base tumors, lower proportion of males, and lower salvage surgery rate were observed in the radiosurgery group than in the surgery group. The median time to malignant change was 5 years (interquartile range = 2.5-8.2), and the median survival after malignant transformation was 4.7 years (95% CI = 3.7-8) in individual case data.
IMT of benign meningioma was significantly affected by the tumor location. Radiosurgery did not appear to increase IMT, but exact comparisons were difficult because of differences in study populations.
良性脑膜瘤恶变的发生率及临床特征尚不清楚。本研究探讨了手术或立体定向放射外科治疗后良性脑膜瘤恶变的风险。
我们使用PubMed、Scopus及其他来源系统回顾了1979年至2019年间发表的研究。我们根据PRISMA指南分析汇总数据,以明确手术或放射外科治疗的良性脑膜瘤恶变发生率(IMT)及影响恶变的因素。
在一项单臂荟萃分析的13项研究中,IMT为2.98/1000患者年(95%置信区间[CI]=1.9 - 4.3)。尽管纳入研究的证据水平较低,但发生率的异质性大多可由肿瘤位置解释。在meta回归分析中,颅底肿瘤的IMT显著低于非颅底肿瘤,但未观察到性别相关性。9项研究中放射外科治疗后的IMT为0.50/1000人年(95%CI = 0.02 - 1.38)。然而,与手术组相比,放射外科组中颅底肿瘤比例更高、男性比例更低且挽救手术率更低。在个体病例数据中,恶变的中位时间为5年(四分位间距=2.5 - 8.2),恶变后的中位生存期为4.7年(95%CI = 3.7 - 8)。
良性脑膜瘤的IMT受肿瘤位置显著影响。放射外科似乎并未增加IMT,但由于研究人群的差异,难以进行精确比较。